ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase"

被引:17
|
作者
Lu, Ying [2 ]
Zhao, Xiaohui [3 ]
Wang, Endi [4 ]
Chen, Wei [5 ]
Huang, Qin [1 ]
机构
[1] City Hope Natl Med Ctr, Div Pathol, Dept Pathol, Duarte, CA 91010 USA
[2] Ningbo 1 Hosp, Dept Hematol, Ningbo, Zhejiang, Peoples R China
[3] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA
[4] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[5] Zhejiang Univ, Coll Med, Sir Run Run Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
Anaplastic large cell lymphoma; Leukemic phase; Bone marrow and blood; POLYMERASE CHAIN-REACTION; OF-THE-LITERATURE; NON-HODGKINS-LYMPHOMA; T-CELL; CLINICOPATHOLOGICAL ENTITY; MALIGNANT HISTIOCYTOSIS; KI-1; LYMPHOMA; VARIANT TYPE; KINASE GENE; TRANSLOCATION;
D O I
10.1016/j.leukres.2009.07.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD30-positive anaplastic large cell lymphoma (ALCL) is a distinctive malignant large cell lymphoma of T-cell lineage, often presenting in lymph node or extranodal sites. ALCL cases with extensive bone marrow and peripheral blood involvement manifested as "leukemic phase" are extremely rare and the most of those cases reported are anaplastic large cell lymphoma kinase (ALK) positive ALCL in childhood population. Here we report four adult cases of ALK-negative ALCL with extensive bone marrow and peripheral blood involvement manifested as "leukemic phase". Circulating large lymphoma cells varied from 20 to 80% in peripheral blood and bone marrow biopsy showed various nodular or interstitial infiltrates. By reviewing the clinicopathologic data of previously reported ALCL cases with extensive bone marrow and peripheral blood involvement, there appears to be of large variations in regard to the patient's age, morphologic variants, immunophenotypic or genotypic characteristics of the disease. While most cases of ALCL with peripheral blood and bone marrow involvement were ALK-positive or carrying t(2; 5) translocation, rare ALK-negative cases were also present. Leukemic ALCL patients usually have unfavourable prognosis, regardless of ALK expression. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 50 条
  • [41] Images from the Haematologica Atlas of Hematologic Cytology: anaplastic large cell lymphoma, ALK-negative
    Invernizzi, Rosangela
    HAEMATOLOGICA, 2022, 107 (12) : 2771 - 2771
  • [42] Molecular Predictors of Treatment Failure in ALK-Negative Anaplastic Large T-Cell Lymphoma
    Gorenkova, Liliya
    Kravchenko, Sergey Kirillovich
    Mkrtchyan, Asmik
    Musyirin, Vsevolod
    Misyurina, Anna Evgenevna
    Savchenko, Valeriy G.
    BLOOD, 2016, 128 (22)
  • [43] ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus
    Suvajdzic, N
    Stpjanovic-Milenkovic, R
    Tomasevic, Z
    Cemerikic-Martinovic, V
    Mikhaljevic, B
    Atkinson, HDE
    MEDICAL ONCOLOGY, 2003, 20 (04) : 409 - 412
  • [44] Recurrent ALK-Negative Anaplastic Large T-Cell Lymphoma Presenting as Necrotizing Vasculitis
    Nambudiri, Vinod E.
    Aboutalebi, Amir
    Granter, Scott R.
    Saavedra, Arturo
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2013, 35 (04) : 512 - 516
  • [45] ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus
    Nada Suvajdzic
    Roksanda Stojanovic-Milenkovic
    Zoran Tomasevic
    Vesna Cemerikic-Martinovic
    Biljana Mihaljevic
    Henry D. E. Atkinson
    Medical Oncology, 2003, 20 : 409 - 412
  • [46] Bcl-2 is expressed in ALK-negative but not ALK-positive anaplastic large cell lymphoma (ALCL).
    Rassidakis, GZ
    Medeiros, LJ
    Herling, M
    Ford, R
    Messina, O
    Cabanillas, F
    Sarris, AH
    BLOOD, 2000, 96 (11) : 128A - 128A
  • [47] Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma
    Lourdes, Laura S.
    Al-Quran, Samer Z.
    Dang, Nam H.
    Markham, Merry-Jennifer
    CASE REPORTS IN HEMATOLOGY, 2012, 2012
  • [48] Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma
    Luchtel, Rebecca A.
    Zimmermann, Michael T.
    Hu, Guangzhen
    Dasari, Surendra
    Jiang, Manli
    Oishi, Naoki
    Jacobs, Hailey K.
    Zeng, Yu
    Hundal, Tanya
    Rech, Karen L.
    Ketterling, Rhett P.
    Lee, Jeong-Heon
    Eckloff, Bruce W.
    Yan, Huihuang
    Gaonkar, Krutika S.
    Tian, Shulan
    Ye, Zhenqing
    Kadin, Marshall E.
    Sidhu, Jagmohan
    Jiang, Liuyan
    Voss, Jesse
    Link, Brian K.
    Syrbu, Sergei I.
    Facchetti, Fabio
    Bennani, N. Nora
    Slager, Susan L.
    Ordog, Tamas
    Kocher, Jean-Pierre
    Cerhan, James R.
    Ansell, Stephen M.
    Feldman, Andrew L.
    BLOOD, 2019, 133 (26) : 2776 - 2789
  • [49] ALK-negative cutaneous anaplastic large cell lymphoma (ALCL) in children frequently relapses.
    Vajpayee, N
    Kepner, J
    Link, MP
    Laver, J
    Murphy, S
    Desai, S
    Schwenn, M
    Tarbell, N
    Fitzgerald, TJ
    Hutchison, RE
    BLOOD, 2000, 96 (11) : 232B - 232B
  • [50] ALK-negative anaplastic large-cell lymphoma (ALCL) presenting as symmetrical axillary nodules
    Bouchard, Jeremy
    Lachance, Madeleine
    Delisle, Bernard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB137 - AB137